Reactive oxygen intermediate-dependent NF-κB activation by interleukin- 1β requires 5-lipoxygenase or NADPH oxidase activity

Molecular and Cellular Biology

Volumn 19, Issue 3, 1999, Pages 1950-1960

  Bonizzi, Giuseppina ^a   Piette, Jacques ^a   Schoonbroodt, Sonia ^a   Greimers, Roland ^a   Havard, Laurence ^a   Merville, Marie Paule ^a   Bours, Vincent ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0033053617     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.3.1950     Document Type: Article

References (67)

1. Abo, A., A. Boyhan, I. West, A. J. Thrasher, and A. W. Segal. 1992. Reconstitution of neutrophil NADPH oxidase activity in the cell-free system by four components: p67-phox. p47-phox. p21racl and cytochrome b-245. J. Biol. Chem. 267:16767-16770.
2. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
3. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071.
4. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301-3310.
5. Bokoch, G. M. 1995. Regulation of the phagocyte respiratory burst by small GTP-binding proteins. Trends Cell Biol. 5:109-113.
6. Bonizzi, G., E. Dejardin, B. Piret, J. Piette, M.-P. Merville, and V. Bours. 1996. IL-1β induces NF-κB in epithelial cells independently of the production of reactive oxygen intermediates. Eur. J. Biochem. 242:544-549.
7. Bonizzi, G., J. Piette, M.-P. Merville, and V. Bours. 1997. Distinct signal transduction pathways mediate nuclear factor-κB induction by IL-1β in epithelial and lymphoid cells. J. Immunol. 159:5264-5272.
8. Bonizzi, G., S. Schoonbroodt, J. Piette, M.-P. Merville, and V. Bours. Implication of the protein kinase C λ/ι isoform in NF-κB activation by IL-1β or TNF-α: cell type specificities. Biochem. Pharmacol., in press.
9. Bours, V., P. R. Burd, K. Brown, J. Villalobos, S. Park, R.-P. Ryseck, R. Bravo, K. Kelly, and U. Siebentist. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:685-695.
10. Bowie, A., P. N. Moynagh, and L. A. J. O'Neill. 1997. Lipid peroxidation is involved in the activation of NF-κB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. J. Biol. Chem. 272: 25941-25950.
11. Brennan, P., and L. A. J. O'Neill. 1995. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta 1260:167-175.
12. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
13. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90:2532-2536.
14. Burns, K., F. Martinen, C. Esslinger, H. Pahl, P. Schneider, J.-L. Bodmer, F. Di Marco, L. French, and J. Tschopp. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273:12203-12209.
15. Can, Z., W. J. Henzel, and X. Gao. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science 271:1128-1131.
16. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443-446.
17. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
18. Coso, O. A., M. Chiarello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137-1148.
19. Diaz-Meco, M. T., E. Berra, M. M. Municio, L. Sanz, J. Lozano, I. Dominguez, V. Diaz-Golpe, M. T. Lain de Lera, J. Alcami, C. V. Payà, F. Arenzana-Seisdedos, J.-L. Virelizier, and J. Moscat. 1993. A dominant negative protein kinase C ζ subspecies blocks NF-κB activation. Mol. Cell. Biol. 13:4770-4775.
20. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcriptional factor NF-κB. Nature 388:548-554.
21. Diekmann, D., A. Abo, C. Johnston, A. W. Segal, and A. Hall. 1994. Interaction of Rac with p67phox and regulation of phagocytic NADPH activity. Science 265:531-533.
22. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
23. Dixon, R. A. F., R. E. Diehl, E. Opas, E. Rands, P. J. Vickers, J. F. Evans, J. W. Gillard, and D. K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282-284.
24. Dominguez, I., L. Sanz, F. Arenzana-Seisdedos, M. T. Diaz-Meco, J.-L. Virelizier, and J. Moscat. 1993. Inhibition of protein kinase C ζ subspecies blocks the activation of an NF-κB-like activity in Xenopus laevis oocytes. Mol. Cell. Biol. 13:1290-1295.
25. Finco, T. S., and A. S. J. Baldwin. 1993. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1. J. Biol. Chem. 268:17676-17679.
26. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/ NF-κB-mediated inhibition. Nature 359:339-342.
27. Friedlander, R. M., V. Gagliardini, R. J. Rotello, and J. Yuan. 1996. Functional role of interleukin 1β (IL-1β) in IL-1β-converting enzyme-mediated apoptosis. J. Exp. Med. 184:717-724.
28. Hardiman, G., F. L. Rock, S. Balasubramanian, R. A. Kastelein, and J. F. Bazan. 1996. Molecular characterization and modular analysis of human MyD88. Oncogene 13:2467-2475.
29. Harrison, K. A., and R. C. Murphy. 1995. Isoleukotrienes are biologically active free radical products of lipid peroxidation. J. Biol. Chem. 270:17273-17278.
30. Huang, J., X. Gao, and Z. Cao. 1997. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. USA 94:12829-12832.
31. Kanakaraj, P., P. H. Schafer, D. E. Cavender, Y. Wu, K. Ngo, P. F. Grealish, S. A. Wadsworth, P. A. Peterson, J. J. Siekierka, C. A. Harris, and W.-P. Fung-Leung. 1998. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187:2073-2079.
32. Kolesnick, R., and D. W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328.
33. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88: 213-222.
34. Lee, S., K. A. Felts, G. C. N. Parry, L. M. Armacost, and R. R. Cobb. 1997. Inhibition of 5-lipoxygenase blocks IL-1β-induced vascular adhesion molecule-1 gene expression in human endothelial cells. J. Immunol. 158:3401-3407.
35. Legrand-Poels, S., D. Vaira, J. Pincemail, A. Van de Vorst, and J. Piette. 1990. Activation of human immunodeficiency virus type 1 by an oxidative stress. AIDS Res. Hum. Retroviruses 6:1389-1397.
36. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway. N. Engl. J. Med. 323:645-655.
37. Los, M., H. Schenk, K. Hexel, P. A. Baeuerle, W. Dröge, and K. Schulze-Osthoff. 1995. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14:3731-3740.
38. Machleidt, T., K. Wiegmann, T. Henkel, S. Schütze, P. Baeuerle, and M. Krönke. 1994. Sphingomyelinase activates proteolytic IκB-α degradation in a cell-free system. J. Biol. Chem. 269:13760-13765.
39. Malinin, N. L., M. P. Boldin, A. V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540-544.
40. Mancini, J. A., P. Prasit, M. G. Coppolino, P. Charleson, S. Leger, J. F. Evans, J. W. Gillard, and P. J. Vickers. 1991. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors. Mol. Pharmacol. 41:267-272.
41. Maniatis, T. 1997. Catalysis by a multiprotein IκB kinase complex. Science 278:818-819.
42. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennet, J. W. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-865.
43. Miller, D. K., J. W. Gillard, P. J. Vickers, S. Sadowski, C. Léveillé, J. A. Mancini, P. Charleson, R. A. F. Dixon, H. A. W. Ford-Hutchinson, and R. Fortin. 1990. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343:278-281.
44. Muzio, M., J. Ni, P. Feng, and V. M. Dixit. 1997 IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612-1615.
45. Pan, Z. K., R. D. Ye, S. C. Christiansen, M. A. Jagels, G. M. Bokoch, and B. L. Zuraw. 1998. Role of the Rho GTPase in bradykinin-stimulated nuclear-κB activation and IL-1β gene expression in cultured epithelial cells. J. Immunol. 160:3038-3045.
46. Perona, R., S. Montaner, L. Saniger, I. Sanchez-Perez, R. Bravo, and J. C. Lacal. 1997. Activation of the nuclear factor-κB by Rho, CDC42 and Rac-1 proteins. Genes Dev. 11:463-475.
47. Régnier, C. H., H. Y. Sung, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe, 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
48. Reid, G. K., S. Kargman, P. J. Vickers, J. A. Mancini, C. Léveillé, D. Ethier, D. K. Miller, J. W. Gillard, R. A. F. Dixon, and J. F. Evans. 1990. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase and cellular leukotriene synthesis. J. Biol. Chem. 265:19818-19823.
49. Rothwarf, D. M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 395:297-300.
50. Schreck, R., K. Albermann, and P. A. Baeuerle. 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17:221-227.
51. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181-1194.
52. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258.
53. Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Krönke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776.
54. Segal, A. W., and A. Abo. 1993. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:43-47.
55. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation, and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
56. Song, H. Y., C. H. Regnier, C. J. Kirschning, D. V. Goeddel, and M. Rothe. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear fuctor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94:9792-9796.
57. Sulciner, D. J., K. Irani, Z.-X. Yu, V. J. Ferrans, P. Goldschmidt-Clermont, and T. Finkel. 1996. racl regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-κB activation. Mol. Cell. Biol. 16:7115-7121.
58. Traenckner, E. B.-M., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
59. Traenckner, E. B.-M., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:5433-5441.
60. Van Elst, L., and C. D'Souza-Schorey. 1997. Rho GTPases and signaling networks, Genes Dev. 11:2295-2322.
61. Wesche, H., W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837-847.
62. Wesche, H., C. Korherr, M. Kracht, W. Falk, K. Resch, and M. U. Martin. 1997. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272:7727-7731.
63. Woods, J. W., J. F. Evans, D. Ethier, S. Scott, P. J. Vickers, L. Hearn, J. A. Heiben, S. Charleson, and I. I. Singer. 1993. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935-1946.
64. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866-869.
65. Yamin, T. T., and D. K. Miller. 1997. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272:21540-21547.
66. Zandi, E., D. M. Rothwarf, M. Delhasse, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252.
67. Zeisler, H., C. Tempfer, E. A. Joura, G. Sliutz, H. Koebl, O. Wagner, and C. Kainz. 1998. Serum interleukin 1 in ovarian cancer patients. Eur. J. Cancer 34:931-933.